Corsens Medical

Corsens Medical Overview

Corsens Medical has developed a lightweight, simple-to-operate, early-warning cardiac alert monitor for home use. Corsens received Pre-Marketing Notification (510(k)- K160656) clearance with the US FDA for its CPM. After the successful completion of initial human clinical trials proving safety and effectiveness, the company is in the process of extending its clinical data in cooperation with hospitals in Israel and preparing its FDA-cleared device for commercialization.

Cumulative Funding Raised Over Time ($)

Latest News

Nov 19, 2016 · www.thefreelibrary.com

growth-positive

Corsens Medical's Cardiac Monitor Granted US FDA Clearance for 510(k) Pre-Marketing Notification.

Corsens Medical Ltd has received clearance for a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration for its Corsens Cardiac Monitor. The monitor is designed to detect cardiac contractility parameters and provide continuous monitoring of heart activity. Corsens Medical is a development stage medical device company based in Tel Aviv, Israel.

Investment

May 2, 2016 · www.businesswire.com

Corsens Medical Ltd., Announces Filing of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Corsens Cardiac Monitor

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Azrieli Center, Derech Menachem Begin, Tel Aviv-Yafo, Israel

Photos & Videos

No files yet

Corsens Medical Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info